Skip to content

Post-market clinical follow-up (PMCF) Plan for Oyster cage

Post-market clinical follow-up (PMCF) Plan for Oyster cage - PMCF Oyster Cage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00027507
Enrollment
70
Registered
2022-01-17
Start date
2021-06-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M42.12 M47.22 M48 M50.0 M50.1 M50.2 M54.12 M54.19

Interventions

Group 1: Patients with chronic pain in the cervical area and/or in the arm area get an Oyster Cage implanted. The Neck Disability Index (NDI) assesses the impairment for these patients preoperative co

Sponsors

Silony Medical GmbH, Clinical Affairs
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria Skeletally mature patients with one of the following indications: + Degenerative disc disease (DDD) + Prolapsed intervertebral disc and symptomatic cervical + Spondylosis + Spondylotic myelopathy and foraminal stenosis + Spine trauma, lesions and revision surgeries + Willingly sign informed consent.

Exclusion criteria

Exclusion criteria: Based on the contra-indications for the device, the following exclusion criteria apply: + Spondylosis + Overweight (BMI > 40) + Implantation in patients with an active infection or pronounced local inflammation in the area of surgery + Severe osteoporosis affecting the spine + Primary or metastatic tumors affecting the spine + Suspected allergy or foreign body reaction to titanium or titanium alloys + Patients whose ability to follow postoperative restrictions, precautions and rehabilitation programs is limited + Fractures, severe deformities or an instability in the area of surgery

Design outcomes

Primary

MeasureTime frame
Functional outcome measured with the Neck Disability Index (NDI)

Secondary

MeasureTime frame
To assess device-related complications of the Oyster® cage, including the + prevalence of revision surgery, + unanticipated complications or + serious adverse device effects or rare events To assess pain relief To assess device performance in terms of restoration of height and cervical lordosis

Countries

Germany

Contacts

Public ContactJana Wilke

Klinik für Spinale Chirurgie, Schön Klinik Holding SE

jwilke@schoen-klinik.de0049 - (0)40 2092 7030

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026